Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study
Michot, Jean-Marie, Bouabdallah, Reda, Vitolo, Umberto, Doorduijn, Jeanette K, Salles, Gilles, Chiappella, Annalisa, Zinzani, Pier Luigi, Bijou, Fontanet, Kersten, Marie José, Sarmiento, Rafael, MosuVolume:
7
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(20)30208-8
Date:
September, 2020
Fichier:
PDF, 434 KB
2020
File converter
Plus de résultats de recherche
More benefits 
